Craig Patrick Ramirez
Principal investigator.
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2020First federal award
$5.6MFederal grants as PI9 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
9 awards · $5.6M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Aug 27, 2026 | NIH | SBIR Phase II A novel monobody-drug conjugate to treat mutant KRas pancreatic cancer. | $929K | — |
| Aug 18, 2026 | NIH | STTR Phase I Tumor-targeted delivery of radio/chemotherapy in pancreatic cancer. | $400K | — |
| Aug 21, 2025 | NIH | SBIR Phase II A novel monobody-drug conjugate to treat mutant KRas pancreatic cancer. | $1.1M | — |
| May 13, 2025 | NIH | SBIR Phase II A novel monobody-drug conjugate to treat mutant Ras multiple myeloma | $206K | — |
| Jul 29, 2024 | NIH | SBIR Phase II A novel monobody-drug conjugate to treat mutant Ras multiple myeloma | $928K | — |
| Jul 20, 2023 | NIH | SBIR Phase II A novel monobody-drug conjugate to treat mutant Ras multiple myeloma | $1.1M | — |
| Aug 24, 2022 | NIH | STTR Phase I A novel monobody-drug conjugate to treat mutant KRas pancreatic cancer. | $210K | — |
| Aug 25, 2021 | NIH | STTR Phase I A novel monobody-drug conjugate to treat mutant KRas pancreatic cancer. | $399K | — |
| Jul 15, 2020 | NIH | STTR Phase I A novel monobody-drug conjugate to treat mutant Ras multiple myeloma | $400K | — |
Peer ranks
Federal funding#53
Awards as PI#67
Patents#27
Companies
No tracked company linked yet.
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.